Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Nursing

Date Submitted: Apr 20, 2020
Date Accepted: Sep 28, 2020

The final, peer-reviewed published version of this preprint can be found here:

Vaccipack, A Mobile App to Promote Human Papillomavirus Vaccine Uptake Among Adolescents Aged 11 to 14 Years: Development and Usability Study

Teitelman A, Gregory EF, Jayasinghe J, Wermers Z, Koo JH, Morone J, Leri C. D, Davis A, Feemster KA

Vaccipack, A Mobile App to Promote Human Papillomavirus Vaccine Uptake Among Adolescents Aged 11 to 14 Years: Development and Usability Study

JMIR Nursing 2020;3(1):e19503

DOI: 10.2196/19503

PMID: 34345789

PMCID: 8279454

Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.

Acceptability of and Intention to use Vaccipack: A mobile application to promote HPV vaccine among parents of adolescents ages 11-14

  • Anne Teitelman; 
  • Emily F. Gregory; 
  • Joshua Jayasinghe; 
  • Zara Wermers; 
  • Ja H. Koo; 
  • Jennifer Morone; 
  • Damien Leri C.; 
  • Annet Davis; 
  • Kristen A. Feemster

ABSTRACT

Background:

Background:

More than 90% of Human Papillomavirus (HPV) related cancers could be prevented by HPV vaccine delivered during teenage years. Yet vaccine uptake in the United States falls short of public health goals.

Objective:

The purpose of this study was to describe development, acceptability, and intention to use a mobile application (app) Vaccipack, designed to promote completion of the teen HPV vaccine series.

Methods:

Development of the mobile health (mHealth) content was based on the Integrated Model of Behavior and the Technology Acceptance Model was used to guide evaluation. Design utilized an iterative process involving potential users who were parents and adolescents. App functions included vaccine tracking, a discussion forum, and stories with embedded messages to promote intention to vaccinate (based on behavioral theory and existing literature). Parents and adolescents completed surveys before and after introducing the app in a pediatric primary care setting with low HPV vaccination rates.

Results:

Fifty-four participants (34 parents and 20 adolescents (11-14 years)) completed surveys. Notably, 75% of adolescents and 88% of parents intended to use the app in the next 2 weeks. Acceptability was high among both groups with 75% or adolescents and 88% of parents indicating Vaccipack was easy to use and 85% of adolescents and 82% of parents perceiving the app would be beneficial.

Conclusions:

MHealth technology, such as Vaccipack, may be an acceptable and nimble platform to provide information to parents and adolescents and advance uptake of this important cancer prevention vaccine.


 Citation

Please cite as:

Teitelman A, Gregory EF, Jayasinghe J, Wermers Z, Koo JH, Morone J, Leri C. D, Davis A, Feemster KA

Vaccipack, A Mobile App to Promote Human Papillomavirus Vaccine Uptake Among Adolescents Aged 11 to 14 Years: Development and Usability Study

JMIR Nursing 2020;3(1):e19503

DOI: 10.2196/19503

PMID: 34345789

PMCID: 8279454

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.